Hiroaki Kasashima

9PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsRadiation therapyMedical robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 13, 2026
Impact of Bevacizumab Relative Dose Intensity and Treatment-Induced Proteinuria on the Efficacy of Trifluridine/Tipiracil Plus Bevacizumab in Metastatic Colorectal Cancer.

|Apr 25, 2026
Simultaneous Establishment of Autologous Colorectal Cancer and Mesothelial Stromal Cell Lines from Malignant Ascites Reveals a Mesothelial-Stromal FGFR3 Axis as a Potential Vulnerability in Peritoneal Metastasis.

|Mar 25, 2026
Circulating Thrombospondin-4-Positive Fibroblasts Might be a Useful Marker for Diagnosis of Gastric Cancer.

Koji Maruo, Masakazu Yashiro, Tomoya Sano

|Nov 23, 2025
Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer.

Kosuke Iwane, Yuki Nakanishi, Yu Muta

|Apr 24, 2025
A Case of Epidermal Cyst in the Retrorectum Safely Resected by a Combined Laparoscopic Approach.

Yusuke Tanaka, Hiroaki Kasashima, Tatsunari Fukuoka

|Apr 12, 2024
D3 lymph node dissection using intracorporeal ultrasound for robotic right hemicolectomy - a video vignette.

Tatsunari Fukuoka, Hiroaki Kasashima, Kishu Kitayama

Pageof 2

Frequent Collaborators

3 joint publications

Jorge Moscat

3 joint publications

Yuki Nakanishi

3 joint publications

Yu Muta

3 joint publications

Maria T Diaz-Meco